Navigation Links
Paragon Bioservices, Inc. Wins 2009 Lilly Global Supplier Award
Date:5/18/2009

BALTIMORE, May 18 /PRNewswire/ -- Paragon Bioservices, Inc., a contract research and manufacturing organization (CRO/CMO), has been awarded the coveted 2009 Lilly Global Supplier Award for exceptional performance in support of Lilly's strategic objectives.

"It is a great honor to be recognized in this manner by such an elite organization and it provides solid reaffirmation of our long-held guiding principles of quality, excellence and superior customer service in the delivery of our work," said Dr. Marco A. Chacon, President and CEO of Paragon Bioservices.

Nominated by Lilly's Elanco affiliate, Paragon Bioservices was one of fifteen companies selected from among 6500 Lilly global suppliers.

About Paragon Bioservices, Inc.

Paragon Bioservices (www.paragonbioservices.com) offers contract services for accelerating the development and manufacturing of biologics. Highly flexible and responsive, we work in partnership with our clients to ensure efficient and cost-effective target validation services, reagent protein production, process development and scale-up production of biopharmaceuticals for research purposes or for Phase I/II clinical trials.

    Contacts:
    Paragon Bioservices, Inc.
    (410) 975-4050
    Todd Carver, VP, Business Services & Administration
    TCarver@paragonbioservices.com

    Richard Lewis Communications, Inc.
    (212) 827-0020
    Gregory Tiberend
    gtiberend@rlcinc.com
    Cecelia Heer
    cheer@rlcinc.com


'/>"/>
SOURCE Paragon Bioservices, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. Bayer CropSciences Vegetable Seed Business Nunhems Acquires US Lettuce Seed Company Paragon Seed
2. Emisphere Technologies, Inc. and Eli Lilly and Company Settle Ongoing Litigation
3. Lilly Declares Fourth-Quarter Dividend
4. Robert Conley, M.D. to Join Lilly; Will assume a neuroscience leadership role as a Distinguished Lilly Scholar
5. Lilly and BioMS Medical Announce Global Licensing and Development Agreement
6. Daiichi Sankyo, Lilly Submit New Drug Application for Investigational Antiplatelet Drug, Prasugrel, with U.S. Food and Drug Administration
7. In response to a New England Journal of Medicine article published yesterday and subsequent media coverage, Eli Lilly and Company issued the following statement:
8. Lilly Announces Termination of AIR Insulin Program
9. HistoRx and Lilly Extend, Expand AQUA(R) Analysis Partnership
10. Pelikan Technologies and Lilly Form Alliance to Promote Diabetes Education
11. Lilly Reports Solid First-Quarter Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/11/2017)... AURORA, Colo. (PRWEB) , ... January 11, 2017 ... ... in the journal Clinical Cancer Research show early promise of the investigational anti-cancer ... progressed despite a median 5 previous treatment regimens. Twenty-seven percent of these heavily ...
(Date:1/11/2017)... ... 11, 2017 , ... With sepsis claiming approximately 500,000 lives ... billion, healthcare systems are looking to provide better and faster care to ... are bacteria and the yeast pathogen Candida, which can lead to severe complications ...
(Date:1/11/2017)... Colorado (PRWEB) , ... January 11, 2017 , ... ... dynamic aqueous plasma technology platforms, announced today that the National Science Foundation (NSF) ... supplement for $500,000. The funds will be used to commercialize the Symbios Tubular ...
(Date:1/11/2017)... GAITHERSBURG, Md. , Jan. 11, 2017 /PRNewswire/ ... clinical-stage gene delivery company, announced today that its ... will present a talk entitled  "AdenoVerse™ platform for ... during the Biotech Showcase at the upcoming Phacilitate ... Miami , Florida.  Dr. Brough,s ...
Breaking Biology Technology:
(Date:1/4/2017)... VEGAS , Jan. 4, 2017  CES ... performance biometric sensor technology, today announced the launch ... sensor systems, the highly-accurate biometric sensor modules ... biometric technology, experience and expertise. The two ... Benchmark designed specifically for hearables, and Benchmark BW2.0, ...
(Date:12/22/2016)... December 22, 2016 SuperCom (NASDAQ: ... solutions for the e-Government, Public Safety, HealthCare, and Finance sectors announced ... has been selected to implement and deploy a community-based supportive services ... Northern California , further expanding its presence in the state. ... This new program, ...
(Date:12/19/2016)... TORONTO , 19 de diciembre de 2016  Mosaic Biomedicals ... el desarrollo acelerado de MSC-1, un anticuerpo humanizado que se espera ... en 2017, con múltiples sitios previstos a lo largo de Europa ... MSC-1 ... factor inhibidor de leucemia (LIF), una citoquina pleiotrópica que se sobreexpresa ...
Breaking Biology News(10 mins):